Curtis Medical Investments Limited Filleted accounts for Companies House (small and micro)

Curtis Medical Investments Limited Filleted accounts for Companies House (small and micro)


false false false false false false false false false true false false false false false false No description of principal activity 2019-01-01 Sage Accounts Production Advanced 2019 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 03135599 2019-01-01 2019-12-31 03135599 2019-12-31 03135599 2018-01-01 2018-12-31 03135599 2018-12-31 03135599 core:FurnitureFittings 2019-01-01 2019-12-31 03135599 bus:RegisteredOffice 2019-01-01 2019-12-31 03135599 bus:LeadAgentIfApplicable 2019-01-01 2019-12-31 03135599 bus:Director1 2019-01-01 2019-12-31 03135599 bus:Director3 2019-01-01 2019-12-31 03135599 bus:Director4 2019-01-01 2019-12-31 03135599 bus:Director5 2019-01-01 2019-12-31 03135599 bus:Director6 2019-01-01 2019-12-31 03135599 core:LandBuildings 2019-12-31 03135599 core:FurnitureFittings 2019-12-31 03135599 core:WithinOneYear 2019-12-31 03135599 core:WithinOneYear 2018-12-31 03135599 core:AfterOneYear 2019-12-31 03135599 core:AfterOneYear 2018-12-31 03135599 core:LandBuildings core:OwnedOrFreeholdAssets 2019-12-31 03135599 core:LandBuildings core:OwnedOrFreeholdAssets 2018-12-31 03135599 core:UKTax 2019-01-01 2019-12-31 03135599 core:UKTax 2018-01-01 2018-12-31 03135599 core:ShareCapital 2019-12-31 03135599 core:ShareCapital 2018-12-31 03135599 core:OtherReservesSubtotal 2019-12-31 03135599 core:OtherReservesSubtotal 2018-12-31 03135599 core:RetainedEarningsAccumulatedLosses 2019-12-31 03135599 core:RetainedEarningsAccumulatedLosses 2018-12-31 03135599 core:MoreThanFiveYears 2019-12-31 03135599 core:MoreThanFiveYears 2018-12-31 03135599 core:CostValuation core:Non-currentFinancialInstruments 2018-12-31 03135599 core:DisposalsRepaymentsInvestments core:Non-currentFinancialInstruments 2019-12-31 03135599 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2019-12-31 03135599 core:CostValuation core:Non-currentFinancialInstruments 2019-12-31 03135599 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2018-12-31 03135599 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2019-12-31 03135599 core:Non-currentFinancialInstruments 2019-12-31 03135599 core:Non-currentFinancialInstruments 2018-12-31 03135599 core:RevaluationInvestmentPropertyDeferredTax 2019-12-31 03135599 core:RevaluationInvestmentPropertyDeferredTax 2018-12-31 03135599 core:LandBuildings 2018-12-31 03135599 core:FurnitureFittings 2018-12-31 03135599 bus:SmallEntities 2019-01-01 2019-12-31 03135599 bus:Audited 2019-01-01 2019-12-31 03135599 bus:FullAccounts 2019-01-01 2019-12-31 03135599 bus:SmallCompaniesRegimeForAccounts 2019-01-01 2019-12-31 03135599 bus:PrivateLimitedCompanyLtd 2019-01-01 2019-12-31 03135599 core:FairValueMovementsOnFinancialInstrumentsDeferredTax 2019-12-31 03135599 core:FairValueMovementsOnFinancialInstrumentsDeferredTax 2018-12-31 03135599 core:OfficeEquipment 2019-01-01 2019-12-31
COMPANY REGISTRATION NUMBER: 03135599
Curtis Medical Investments Limited
Filleted Financial Statements
For the year ended
31 December 2019
Curtis Medical Investments Limited
Financial Statements
Year ended 31st December 2019
Contents
Pages
Officers and professional advisers
1
Statement of financial position
2 to 3
Notes to the financial statements
4 to 11
Curtis Medical Investments Limited
Officers and Professional Advisers
The board of directors
Mr M Hill
Mr A Bunker
Mr J J Hill
Mr M W Seaman-Hill
Mrs K M A Hill
Registered office
First Floor Offices
99 Bancroft
Hitchin
Hertfordshire
SG5 1NQ
Auditor
Hicks and Company
Chartered accountants & statutory auditors
First Floor
99 Bancroft
Hitchin
Hertfordshire
SG5 1NQ
Bankers
Weatherbys Bank Limited
Sanders Road
Wellingborough
Northamptonshire
NN8 4BX
Curtis Medical Investments Limited
Statement of Financial Position
31 December 2019
2019
2018
Note
£
£
£
Fixed assets
Tangible assets
6
23,884,926
23,884,926
Investments
7
299,764
420,098
-------------
-------------
24,184,690
24,305,024
Current assets
Debtors
8
514,997
302,270
Investments
9
1,717
1,878
Cash at bank
739,226
988,340
------------
------------
1,255,940
1,292,488
Creditors: amounts falling due within one year
10
1,297,103
1,547,790
------------
------------
Net current liabilities
41,163
255,302
-------------
-------------
Total assets less current liabilities
24,143,527
24,049,722
Creditors: amounts falling due after more than one year
11
6,113,787
6,642,973
Provisions
Taxation including deferred tax
1,104,208
1,101,097
-------------
-------------
Net assets
16,925,532
16,305,652
-------------
-------------
Capital and reserves
Called up share capital
100
100
Fair value reserve
12,243,689
12,246,576
Profit and loss account
4,681,743
4,058,976
-------------
-------------
Shareholders funds
16,925,532
16,305,652
-------------
-------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
Curtis Medical Investments Limited
Statement of Financial Position (continued)
31 December 2019
These financial statements were approved by the board of directors and authorised for issue on 14 August 2020 , and are signed on behalf of the board by:
Mr M W Seaman-Hill
Director
Company registration number: 03135599
Curtis Medical Investments Limited
Notes to the Financial Statements
Year ended 31st December 2019
1. General information
The company is a private company limited by shares, registered in England and Wales, registered number 03135599 . The address of the registered office is First Floor Offices, 99 Bancroft, Hitchin, Hertfordshire, SG5 1NQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and investment properties measured at fair value through profit or loss. The financial statements are prepared in pounds sterling, which is also the functional currency of the company. Monetary amounts are rounded to the nearest pound.
Going concern
The directors are satisfied with the financial arrangements of the company and that the financial statements are appropriately prepared on a going concern basis.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover represents the rents of properties and recharged expenses which are included on an accruals basis and consultancy fees excluding value added tax on properties where option to tax has been granted by H M Revenue & Customs.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Payments made under operating leases are charged to the Profit and Loss Account on a straight line basis over the lease term.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Furniture, fixtures and fittings
-
20% straight line
Office equipment
-
20% straight line
No depreciation is provided in the year of purchase with a full years charge in the year of disposal.
Investment property
Investment property is initially recorded at cost, which includes purchase price and any directly attributable expenditure. Investment property is revalued to its fair value at each reporting date and any changes in fair value are recognised in profit or loss. If a reliable measure of fair value is no longer available without undue cost or effort for an item of investment property, it shall be transferred to tangible assets and treated as such until it is expected that fair value will be reliably measurable on an on-going basis.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in subsidiaries
Investments in subsidiaries accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in subsidiaries accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the subsidiary arising before or after the date of acquisition.
Impairment of fixed assets
At each reporting date, the company reviews the carrying amount of its fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 5 (2018: 5 ).
5. Tax on profit
Major components of tax expense
2019
2018
£
£
Current tax:
UK current tax expense
208,822
202,036
Deferred tax:
Origination and reversal of timing differences
3,111
3,772
---------
---------
Tax on profit
211,933
205,808
---------
---------
Reconciliation of tax expense
The tax assessed on the profit on ordinary activities for the year is lower than (2018: lower than) the standard rate of corporation tax in the UK of 19 % (2018: 19 %).
2019
2018
£
£
Profit on ordinary activities before taxation
1,231,813
1,105,610
------------
------------
Profit on ordinary activities by rate of tax
234,044
210,065
Effect of expenses not deductible for tax purposes
( 24,546)
( 6,684)
Effect of capital allowances and depreciation
( 143)
( 174)
Effect of revenue exempt from tax
( 533)
( 1,171)
Deferred tax adjustment on fair value adjustment of fixed assets
3,111
3,772
------------
------------
Tax on profit
211,933
205,808
------------
------------
6. Tangible assets
Freehold investment properties
Furniture, fixtures and fittings
Total
£
£
£
Cost or Valuation
At 1st January 2019 and 31st December 2019
23,883,418
529,299
24,412,717
-------------
---------
-------------
Depreciation
At 1st January 2019 and 31st December 2019
527,791
527,791
-------------
---------
-------------
Carrying amount
At 31st December 2019
23,883,418
1,508
23,884,926
-------------
---------
-------------
At 31st December 2018
23,883,418
1,508
23,884,926
-------------
---------
-------------
Included within the above is investment property as follows:
£
-------------
At 1st January 2019 and 31st December 2019
23,883,418
-------------
The fair value of the freehold investment properties have been arrived at on the basis of valuations carried out by the directors of the company. The valuations were made on an open market value, value evidence basis for existing use on 31st December 2019.
Tangible assets held at valuation
In respect of tangible assets held at valuation, the aggregate cost, depreciation and comparable carrying amount that would have been recognised if the assets had been carried under the historical cost model are as follows:
Freehold investment properties
£
At 31st December 2019
Aggregate cost
10,736,998
Aggregate depreciation
-------------
Carrying value
10,736,998
-------------
At 31st December 2018
Aggregate cost
10,736,998
Aggregate depreciation
-------------
Carrying value
10,736,998
-------------
7. Investments
Shares in participating interests
Other investments other than loans
Total
£
£
£
Cost or Valuation
At 1st January 2019
50
506,197
506,247
Disposals
( 206,707)
( 206,707)
Fair value adjustment
224
224
----
---------
---------
At 31st December 2019
50
299,714
299,764
----
---------
---------
Impairment
At 1st January 2019
86,149
86,149
Reversal of impairment losses
( 86,149)
( 86,149)
----
---------
---------
At 31st December 2019
----
---------
---------
Carrying amount
At 31st December 2019
50
299,714
299,764
----
---------
---------
At 31st December 2018
50
420,048
420,098
----
---------
---------
Shares in participating interest
Shares held in the participating interest by the company relates to Curtis Medical Investments (Letchworth) Limited:
Name of Company - Curtis Medical Investments (Letchworth) Limited
Country of Incorporation - England & Wales
Holding - Ordinary Shares
Proportion Held - 50%
Nature of Business - Property Investment and Development
Extracts from the audited financial statements of the participating interest at 31st December 2019 are as follows:
Capital and Reserves £493,932
Profit for the year after taxation £ 27,352
Investments held at valuation
The fair value of quoted investments is the market price in an active market on 31st December 2019.
Unquoted investments are valued by the directors on an appropriate valuation basis, with due consideration for the size of the holding.
In respect of investments held at valuation, the aggregate cost, depreciation and comparable carrying amount that would have been recognised if the assets had been carried under the historical cost model are as follows:
Other investments other than loans
£
At 31st December 2019
Aggregate cost
98,237
Aggregate depreciation
--------
Carrying value
98,237
--------
At 31st December 2018
Aggregate cost
304,944
Aggregate depreciation
---------
Carrying value
304,944
---------
8. Debtors
2019
2018
£
£
Insurance arrears
532
873
Amounts owed by group undertakings and undertakings in which the company has a participating interest
11,000
Other debtors
503,465
301,397
---------
---------
514,997
302,270
---------
---------
9. Investments
2019
2018
£
£
Current asset Investments
1,717
1,878
-------
-------
10. Creditors: amounts falling due within one year
2019
2018
£
£
Bank loans (secured)
529,186
490,805
Trade creditors
31,618
31,616
Corporation tax
208,822
202,036
Social security and other taxes
52,511
48,425
Rent and insurance in advance
281,179
629,670
Other creditors
193,787
145,238
------------
------------
1,297,103
1,547,790
------------
------------
11. Creditors: amounts falling due after more than one year
2019
2018
£
£
Bank loans (secured)
6,113,787
6,642,973
------------
------------
Included within creditors: amounts falling due after more than one year is an amount of £315,988 (2018: £4,523,980) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.
The bank loans are secured by a first charge over the freehold investment properties.
12. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2019
2018
£
£
Included in provisions
1,104,208
1,101,097
------------
------------
The deferred tax account consists of the tax effect of timing differences in respect of:
2019
2018
£
£
Fair value adjustment of investment property
1,069,573
1,069,573
Other revaluations
34,635
31,524
------------
------------
1,104,208
1,101,097
------------
------------
13. Financial instruments
The carrying amount for each category of financial instrument is as follows:
2019
2018
£
£
Financial assets measured at fair value through profit or loss
Fixed asset investments
256,449
419,667
---------
---------
14. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2019
2018
£
£
Later than 5 years
65,608
77,018
--------
--------
15. Contingencies
As at 31st December 2019 the following contingent liability existed: Additional purchase consideration of £10,000 in respect of an investment property purchased during the year ended 31st December 1998 upon obtaining a final satisfactory surveyor's report. To date this remains to be resolved.
16. Summary audit opinion
The auditor's report for the year dated 14 August 2020 was unqualified.
The senior statutory auditor was PHILIP DEAN FCA , for and on behalf of Hicks and Company .
17. Related party transactions
Included in other debtors are the following loans made to businesses in which certain directors have an interest:
2019 2018
£ £
Curtis Land Limited 50,000 50,000
The above existing loan is unsecured, repayable on demand and subject to interest at 3% per annum.
2019 2018
£ £
Peaktoll Limited 50,000 50,000
Mahone Bay Limited 50,000 50,000
Messrs John Shilcock 38,000 40,000
The above existing loans are unsecured, repayable on demand and subject to interest at 2.5% per annum.